Frontiers | The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy
Frontiers | The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy,Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy | Molecular Cancer | Full Text,Development of PD-L1 Antibody Drug Conjugates (ADC) | Biopharma PEG,IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy - ScienceDirect,HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models | Scientific Reports